Skip to main content

Advertisement

SpringerLink
Log in

Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Pfaller MA, Boyken L, Messer SA, Tendolkar S, Hollis RJ, Diekema DJ (2004) Evaluation of the Etest method using Mueller–Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species. J Clin Microbiol 42:4977–4979

    Article  PubMed  CAS  Google Scholar 

  2. Pappas PP, Rex JHJ, Sobel D et al (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38:161–189

    Article  PubMed  Google Scholar 

  3. Majoros L, Kardos G, Miszti C, Szabó J, Szabó B (2003) Changes in species distribution of yeasts isolated in the University of Debrecen during a six year period. 23rd International Specialised Symposium on Yeasts, Abstract no. O-6-05

  4. National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. NCCLS Wayne, Pa

    Google Scholar 

  5. Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller ME (1998) Influence of test conditions on antifungal time–kill curve results for standardized methods. Antimicrob Agents Chemother 42:1207–1212

    PubMed  CAS  Google Scholar 

  6. Lewis RE, Wiederhold NP, Prince RA, Kontoyiannis DP (2006) In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. J Antimicrob Chemother 57:288–293

    Article  PubMed  CAS  Google Scholar 

  7. Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A (2004) Patterns of amphotericin B killing kinetics against seven Candida species. Antimicrob Agents Chemother 48:2477–2482

    Article  PubMed  Google Scholar 

  8. Lewis RE, Wiederhold NP (2003) The solubility ceiling: a rationale for continuous infusion amphotericin B therapy? Clin Infect Dis 37:871–872

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary

    L. Majoros, G. Kardos & J. Kónya

  2. Department of Pediatrics, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary

    I. Szegedi, C. Erdész & C. Kiss

Authors
  1. L. Majoros
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Szegedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Kardos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Erdész
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Kónya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Kiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Majoros.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Majoros, L., Szegedi, I., Kardos, G. et al. Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study. Eur J Clin Microbiol Infect Dis 25, 803–806 (2006). https://doi.org/10.1007/s10096-006-0200-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-006-0200-5

Keywords

Search

Navigation